CN114438163B - Fungus screening reagent, screening method, kit and application - Google Patents
Fungus screening reagent, screening method, kit and application Download PDFInfo
- Publication number
- CN114438163B CN114438163B CN202210103372.1A CN202210103372A CN114438163B CN 114438163 B CN114438163 B CN 114438163B CN 202210103372 A CN202210103372 A CN 202210103372A CN 114438163 B CN114438163 B CN 114438163B
- Authority
- CN
- China
- Prior art keywords
- screening
- reagent
- crrna
- lysozyme
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012216 screening Methods 0.000 title claims abstract description 57
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 34
- 241000233866 Fungi Species 0.000 title claims abstract description 12
- 102000016943 Muramidase Human genes 0.000 claims abstract description 15
- 108010014251 Muramidase Proteins 0.000 claims abstract description 15
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 15
- 229960000274 lysozyme Drugs 0.000 claims abstract description 15
- 239000004325 lysozyme Substances 0.000 claims abstract description 15
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 15
- 108091005804 Peptidases Proteins 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 10
- 239000000600 sorbitol Substances 0.000 claims abstract description 10
- 238000013461 design Methods 0.000 claims abstract description 6
- 238000001514 detection method Methods 0.000 claims description 22
- 108700004991 Cas12a Proteins 0.000 claims description 17
- 230000001580 bacterial effect Effects 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 101800005109 Triakontatetraneuropeptide Proteins 0.000 claims description 5
- NMEHNETUFHBYEG-IHKSMFQHSA-N tttn Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 NMEHNETUFHBYEG-IHKSMFQHSA-N 0.000 claims description 5
- 230000002538 fungal effect Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 26
- 241000237858 Gastropoda Species 0.000 abstract description 14
- 238000005516 engineering process Methods 0.000 abstract description 8
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 abstract description 6
- 239000012634 fragment Substances 0.000 abstract description 5
- 102000035195 Peptidases Human genes 0.000 abstract description 3
- 239000013612 plasmid Substances 0.000 abstract description 3
- 235000019833 protease Nutrition 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 238000013537 high throughput screening Methods 0.000 abstract description 2
- 238000004904 shortening Methods 0.000 abstract 1
- 239000000872 buffer Substances 0.000 description 9
- 235000019419 proteases Nutrition 0.000 description 9
- 239000012154 double-distilled water Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 230000001420 bacteriolytic effect Effects 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108091033409 CRISPR Proteins 0.000 description 2
- 238000010354 CRISPR gene editing Methods 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 210000001726 chromosome structure Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- -1 pectase Proteins 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of colony screening, in particular to a fungus screening reagent, a screening method, a kit and application. The invention provides a lysozyme reagent, which comprises the following components: sorbitol 0.8-1.1 mol/L, EDTA 10-20 mol/L, snail proteinase 5-60 mg/mL. The CRISPRCas12a technology is applied to fungus colony screening for the first time, and is improved and optimized based on the technical principle, so that the method is more suitable for high-throughput screening. In plasmid design, the invention creatively introduces PAM sequences at the gene terminal, so that all crRNA sequences can simultaneously recognize gene fragments and vector fragments. In addition, the invention utilizes automatic equipment and a large batch of screening reaction systems and conditions to ensure that the method is fully suitable for an automatic scheme of colony screening, thereby greatly shortening the screening time and greatly improving the strain breeding speed and the strain screening efficiency.
Description
Technical Field
The invention relates to the field of colony screening, in particular to a fungus screening reagent, a screening method, a kit and application.
Background
In engineering bacteria transformation process, positive monoclonal colonies are often required to be screened out for further transformation and culture. In the existing method, colony PCR is widely applied to engineering bacteria positive monoclonal screening work as a most rapid and convenient screening method. In the case of fungi, the sample pretreatment is required for colony PCR because of the cell wall and chromosome structure:
Taking 1.5mL of yeast strain in logarithmic growth phase, 13000r/min, centrifuging for 15s, removing supernatant, washing once with double distilled water, centrifuging for 15s at 13000r/min, suspending the precipitate in 200 mu L of TE buffer, boiling for 1-10 min in boiling water, ice-bath for 10min,13000r/min, centrifuging for 5min, storing the supernatant at-20 ℃ and taking 1 mu L for PCR. Or taking dry yeast colony with diameter larger than 3mm, covering the EP tube with a cover, heating in a microwave oven, adding 30 μL TE for shaking, 13000r/min, centrifuging for 2-5 min, storing supernatant in a bath at-20deg.C, and taking 1 μL for PCR. Then the size of the amplified sequence is analyzed and compared to achieve the aim of selecting positive monoclonal.
Because of the high flux and automation requirements of the research and development platform, the existing colony PCR technology cannot realize automatic substitution because the screening result is based on DNA gel electrophoresis, and the screening method of colony PCR and gel electrophoresis is long in time consumption and unfavorable for improving flux.
Disclosure of Invention
In view of this, the invention provides fungal screening reagents, screening methods, kits and uses.
The invention aims to develop a colony screening technology which is applicable to an automatic platform and is more rapid and effective, namely a rapid colony screening technology based on snail protease and Cas12a protein. The key point of the invention is that CRISPR CAS a technology is applied to fungus colony screening for the first time, and is improved and optimized based on the technical principle, so that the technology is more suitable for high-throughput screening. In plasmid design, the invention creatively introduces PAM sequences at the gene terminal, so that all crRNA sequences can simultaneously recognize gene fragments and vector fragments. In addition, the invention utilizes automatic equipment, a large batch of screening reaction systems and reaction conditions, so that the method is fully applicable to an automatic implementation scheme of colony screening, and greatly improves the strain breeding speed and strain screening efficiency.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a lysozyme reagent, which comprises the following components:
Sorbitol 0.8-1.1 mol/L
EDTA 10~20mol/L
Snail proteinase 5-60 mg/mL.
In some embodiments of the invention, the above-described bacteriolytic reagent comprises sorbitol 0.9mol/L.
In some embodiments of the invention, the above-described bacteriolytic reagent comprises EDTA 10mol/L.
In some embodiments of the invention, the above-described bacteriolytic reagent comprises 30mg/mL of snail protease.
The invention also provides a detection reagent, which comprises the following components:
1μM crRNA 20~200nM
10nM Cas12a protein 0.2-0.5 nM
1NM fluorescent reporter 0.1-0.5 nM
The volume ratio of 10 x buffer to ddH 2 O is 1:6.
In some embodiments of the invention, the detection reagent comprises 1. Mu.M crRNA100nM.
In some embodiments of the invention, the detection reagent comprises 10nM of the Cas12a protein 0.5nM.
In some embodiments of the invention, the detection reagent comprises 1nM fluorescent reporter 0.1nM.
The invention also provides a method for designing the crRNA of the detection reagent, which comprises the step of selecting a base sequence of 20bp after a PAM locus TTTN on a target gene as a recognition sequence.
The invention also provides screening reagents, including the above-described bacteriolytic reagents and/or the above-described detection reagents.
The invention also provides a screening method of fungus colonies, which comprises the following steps:
s1: mixing the lysozyme and/or the lysozyme in the screening reagent with a sample to obtain a mixed bacterial solution;
S2: mixing the mixed bacterial liquid with the detection reagent and/or the detection reagent in the screening reagent, and detecting.
In some embodiments of the invention, the mixing time in the above screening method S1 is 10 to 50 minutes and the temperature is 35 to 38 ℃.
In some embodiments of the invention, the mixing time in the above screening method S1 is 30min.
In some embodiments of the invention, the temperature of the mixing in the above screening method S1 is 37 ℃.
In some embodiments of the invention, the volume ratio of the lysozyme to the sample in the screening method S1 is 35:1.
In some embodiments of the invention, the time of the mixing in the screening method S2 is 15min and the temperature is 35-38 ℃.
In some embodiments of the present invention, the temperature of the mixing in the screening method S2 is 37 DEG C
The invention also provides a kit comprising the above-mentioned lysozyme, the above-mentioned detection reagent and/or the above-mentioned screening reagent and an acceptable auxiliary agent.
The invention also provides application of the lysozyme, the detection reagent, the screening reagent and/or the kit in detecting and/or screening fungus colonies.
The invention provides a lysozyme reagent, which comprises the following components:
Sorbitol 0.8-1.1 mol/L
EDTA 10~20mol/L
Snail proteinase 5-60 mg/mL.
The invention changes the method and technology for screening target colony against the deficiency of the existing colony PCR, breaks through the flux limit of colony screening instruments (electrophoresis apparatus and PCR apparatus), and can realize maximum flux screening. Meanwhile, the screening time is shortened from 3 hours to 1 hour, and the screening efficiency is greatly improved.
Comparison of colony PCR technique
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below.
FIG. 1 illustrates a process for the modification of a degerming system;
FIG. 2 shows the results of the reaction system test;
FIG. 3 shows the pPIC9K-CT05 vector;
FIG. 4 shows the results of the novel method screen;
wherein: + is positive internal reference, 1-5 show positive, namely target colony;
FIG. 5 shows colony PCR screening results;
Wherein: m is marker, 1-5 show positive, namely target colony.
Detailed Description
The invention discloses a fungus screening reagent, a screening method, a kit and application.
It should be understood that the expression "one or more of … …" individually includes each stated object after the expression and various combinations of two or more of the stated objects unless otherwise understood from the context and usage. The expression "and/or" in combination with three or more recited objects should be understood as having the same meaning unless otherwise understood from the context.
The use of the terms "comprising," "having," or "containing," including grammatical equivalents thereof, should generally be construed as open-ended and non-limiting, e.g., not to exclude other unrecited elements or steps, unless specifically stated otherwise or otherwise understood from the context.
It should be understood that the order of steps or order of performing certain actions is not important so long as the invention remains operable. Furthermore, two or more steps or actions may be performed simultaneously.
The use of any and all examples, or exemplary language, such as "e.g." or "comprising" herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Furthermore, the numerical ranges and parameters setting forth the present invention are approximations that may vary as precisely as possible in the exemplary embodiments. However, any numerical value inherently contains certain standard deviations found in their respective testing measurements. Accordingly, unless explicitly stated otherwise, it is to be understood that all ranges, amounts, values and percentages used in this disclosure are modified by "about". As used herein, "about" generally means that the actual value is within plus or minus 10%, 5%, 1% or 0.5% of a particular value or range.
The snail protease provided by the invention is purchased from Holly (the product name is Snailase snail enzyme, the product number is 10404ES 08), and raw materials and reagents used in fluorescence detection and identification tests can be purchased from the market.
Abbreviations and English | Meaning of |
PCR | Polymerase chain reaction |
crRNA | Gene editing specific guide RNA |
Tri-HCl | Trimethylolaminomethane hydrochloride |
Cas12a proteins | Gene editing proteins |
Buffer | Reaction buffer |
PAM site | Cas12a protein recognition site |
TTTN | Nucleic acid sequence, N is A, T, C, G |
EDTA | Ethylenediamine tetraacetic acid |
The invention is further illustrated by the following examples:
EXAMPLE 1 snail protease disruption
Raw materials and reagents: the snail protease is obtained from Yisheng, the cord bag of snail and the mixed enzyme prepared in digestive tract, and contains more than 20 enzymes such as cellulase, pectase, amylase, protease, etc.
And (3) preparation of a reagent: 0.9mol/L sorbitol, snail protein (30 mg/ml) was dissolved in 0.9mol/L sorbitol, 10mol/L EDTA
BufferI:0.9mol/L sorbitol, 0.1mol/L EDTA (0.9 mol/L sorbitol: 10mol/L EDTA=1:100)
The experimental steps are as follows:
Adding 30 mu L bufferI and 5 mu L snail protease solution into the monoclonal, water-bathing for 30min at 37 ℃, and shaking once in 5 min, so as to prevent the cells from sinking to the bottom of the tube, thus obtaining the mixed bacterial liquid.
As the broken thalli and DNA are released in a large amount, the reaction system is sticky and is unfavorable for pipetting operation, so the key point of the step is to adjust the bacterial breaking efficiency according to the detection sensitivity requirement. The invention aims at balancing the bacteria breaking efficiency, the system viscosity and the detection sensitivity, so that the whole screening system is more efficient and is beneficial to operation. So that the invention has great advantages in practical application. The process of the bacteria breaking system is shown in figure 1.
The reaction is carried out at the optimal temperature of 37 ℃, and in order to realize the balance and unification of normal pipetting and release of the bacterial-destroying plasmids of the system viscosity, a large number of verification experiments are carried out on the concentration and the reaction time of lysozyme. As shown in FIG. 1, we set 12 groups of lysozyme concentrations, 5mg/mL, 10mg/mL, 15mg/mL, 20mg/mL, 25mg/mL, 30mg/mL, 35mg/mL, 40mg/mL, 45mg/mL, 50mg/mL, 55mg/mL, 60mg/mL, and 9 groups of reaction time tests, 10min, 15min, 20min, 25min, 30min, 35min, 40min, 45min, 50min, respectively.
There were 108 experimental groups, each with eight parallel controls, and 864 total bacterial responses, and the test results are shown in table 1:
TABLE 1 bacterial disruption reaction
Test results | 10min | 15min | 20min | 25min | 30min | 35min | 40min | 45min | 50min |
5mg/mL | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- |
10mg/mL | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- |
15mg/mL | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- | 1- |
20mg/mL | 1- | 1- | 1- | 1- | 1- | 1- | 1+/- | 1+/- | 1+ |
25mg/mL | 1- | 1- | 1- | 1+/- | 1+/- | 1+ | 1+ | 1+ | 1+ |
30mg/mL | 1- | 1+/- | 1+/- | 1+ | 1+ | 1+ | 1+ | 1+ | 1+ |
35mg/mL | 1+/- | 1+/- | 1+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
40mg/mL | 1+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
45mg/mL | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
50mg/mL | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
55mg/mL | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
60mg/mL | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ | 0+ |
The result shows that the liquid viscosity is influenced by the bacteria breaking system, so that the pipetting process is difficult to carry out, and when the liquid viscosity is moderate, pipetting is realized, and when the liquid viscosity is too high, pipetting is not realized; "pipettable" is denoted by 1 and not pipettable by 0. Because the concentration of the fragment to be detected is influenced by the bacteria breaking system, the high concentration is detectable, and the low concentration is undetectable; "detectable" is indicated by +, and undetectable by-is indicated by- ".
The label "bold and underline" is an alternative system to meet the detection requirements
In combination with efficiency, cost and accuracy, we choose the lowest concentration dosage and the fastest detection time as possible, and ensure the detection accuracy, so 30mg/mL snail protease reaction for 30min is chosen as the final reaction system.
Example 2 fluorescence detection
TABLE 2 statistics of reaction system test results
Table 3 System 1
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 1μL | 20nM |
10NM Cas12a protein | 1μL | 0.2nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 13μL | - |
Mixed bacterial liquid | 2μL | - |
Table 4 System 2
Table 5 System 3
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 100nM |
10NM Cas12a protein | 1μL | 0.2nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
Table 6 System 4
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 200nM |
10NM Cas12a protein | 1μL | 0.2nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
Table 7 System 5
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 200nM |
10NM Cas12a protein | 1μL | 0.5nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
Table 8 System 6
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 150nM |
10NM Cas12a protein | 1μL | 0.5nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
Table 9 System 7
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 100nM |
10NM Cas12a protein | 1μL | 0.5nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
Table 10 CRISPR Cas12a detection technology reaction system
Reagent(s) | Dosage of | Final reaction concentration |
1μM crRNA | 2μL | 100nM |
10NM Cas12a protein | 1μL | 0.5nM |
1NM fluorescent reporter | 1μL | 0.1nM |
10*Buffer | 2μL | - |
ddH2O | 12μL | - |
Mixed bacterial liquid | 2μL | - |
The final protein concentration was determined to be 0.5nM. The higher the crRNA concentration is, the better the crRNA concentration is, and the best effect is obtained when the crRNA concentration in the final reaction system is 100nM after multiple tests. From system 1 to system 4, we consider that crRNA concentrations are too low for specific recognition to be achieved, thus increasing crRNA concentrations to 200nM in system 4. However, the situation is not changed, and it is hypothesized that the Cas12a protein concentration is too low, so that in the system 5 we increase the Cas12a protein concentration to 0.5nM, a false negative phenomenon occurs, that is, a part of positive samples are not detected, so that in the systems 6 and 7 we override the previously elevated crRNA concentration, and gradually decrease the crRNA concentration on the current basis to obtain that the final concentration is 100nM, and the percent detection can be realized. After the above-mentioned debugging (see fig. 2, table 2 for part of the debugging process), the final reaction system was determined (table 10).
Under the reaction system, the experimental result can be observed under ultraviolet light only by adding the prepared system into a sample to be detected and then placing the sample into the reaction system for reaction for 20min at 37 ℃.
Example 3crRNA design
Different screening genes design different crrnas. And selecting a PAM locus (TTTN) on a target gene, selecting a 20bp base sequence after the locus as a recognition sequence, and designing crRNA.
5'UAAUUUCUACUAAGUGUAGAUGAUUGCCGGACCCGGACCGC 3' (shown as SEQ ID NO: 1)
Wherein: the non-underlined part is the structural sequence and the underlined part is the recognition sequence.
Example 4 identification of whether the screening pichia pastoris is a positive monoclonal vector sequence with the pPIC9K-CT05 vector:
AGATCTAACATCCAAAGACGAAAGGTTGAATGAAACCTTTTTGCCATCCGACATCCACAGGTCCATTCTCACACATAAGTGCCAAACGCAACAGGAGGGGATACACTAGCAGCAGACCGTTGCAAACGCAGGACCTCCACTCCTCTTCTCCTCAACACCCACTTTTGCCATCGAAAAACCAGCCCAGTTATTGGGCTTGATTGGAGCTCGCTCATTCCAATTCCTTCTATTAGGCTACTAACACCATGACTTTATTAGCCTGTCTATCCTGGCCCCCCTGGCGAGGTTCATGTTTGTTTATTTCCGAATGCAACAAGCTCCGCATTACACCCGAACATCACTCCAGATGAGGGCTTTCTGAGTGTGGGGTCAAATAGTTTCATGTTCCCCAAATGGCCCAAAACTGACAGTTTAAACGCTGTCTTGGAACCTAATATGACAAAAGCGTGATCTCATCCAAGATGAACTAAGTTTGGTTCGTTGAAATGCTAACGGCCAGTTGGTCAAAAAGAAACTTCCAAAAGTCGCCATACCGTTTGTCTTGTTTGGTATTGATTGACGAATGCTCAAAAATAATCTCATTAATGCTTAGCGCAGTCTCTCTATCGCTTCTGAACCCCGGTGCACCTGTGCCGAAACGCAAATGGGGAAACACCCGCTTTTTGGATGATTATGCATTGTCTCCACATTGTATGCTTCCAAGATTCTGGTGGGAATACTGCTGATAGCCTAACGTTCATGATCAAAATTTAACTGTTCTAACCCCTACTTGACAGCAATATATAAACAGAAGGAAGCTGCCCTGTCTTAAACCTTTTTTTTTATCATCATTATTAGCTTACTTTCATAATTGCGACTGGTTCCAATTGACAAGCTTTTGATTTTAACGACTTTTAACGACAACTTGAGAAGATCAAAAAACAACTAATTATTCGAAGGATCCAAACGATGAGATTTCCTTCAATTTTTACTGCAGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATTTTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTATGCACCACCATCATCACCATACTTCTCGTGACGGCTACCAATGGACACCTGAAACTGGTTTGACTCAGGGTGTGCCATCCCTAGGAGTTATCTCTCCACCAACGAACATAGAGGACACGGATAAGGACGGCCCTTGGGACGTGATCGTAATTGGAGGAGGATATTGCGGTTTAACTGCAACACGTGATCTCACTGTAGCCGGTTTTAAGACTTTATTGTTAGAGGCAAGAGATCGTATTGGAGGTAGATCGTGGTCCTCCAATATTGACGGTTATCCTTACGAAATGGGTGGGACCTGGGTTCATTGGCACCAATCTCATGTGTGGAGAGAGATCACACGTTACAAAATGCATAATGCTTTGTCCCCCTCCTTCAACTTTTCAAGAGGTGTCAACCACTTTCAACTGAGAACAAATCCAACAACCTCGACATATATGACTCATGAAGCAGAGGATGAATTGCTTAGATCAGCTTTGCATAAGTTCACAAATGTTGACGGTACGAACGGCAGAACTGTTTTACCGTTCCCTCACGATATGTTCTATGTCCCCGAATTTCGAAAATACGACGAGATGAGTTACTCCGAACGTATTGATCAAATACGTGATGAATTGAGTCTGAATGAGAGAAGCAGCCTAGAAGCATTCATCCTGTTGTGTTCAGGTGGTACACTTGAAAACTCTTCGTTCGGAGAATTTCTCCATTGGTGGGCTATGTCTGGTTACACATATCAGGGTTGTATGGATTGTCTAATGAGCTATAAGTTTAAGGATGGTCAGAGTGCTTTTGCTAGAAGATTCTGGGAAGAGGCTGCTGGAACTGGTAGATTGGGATACGTTTTCGGTTGTCCTGTCAGGTCCGTGGTTAACGAAAGGGATGCTGCAAGAGTAACAGCAAGAGATGGTCGTGAATTTGCCGCTAAAAGGCTGGTTTGTACTATTCCATTGAATGTCTTGTCCACCATTCAATTTAGTCCAGCACTTTCAACAGAACGTATTAGCGCCATGCAGGCTGGTCATGTGAGCATGTGCACCAAAGTTCACGCAGAAGTTGACAACAAGGACATGAGATCATGGACTGGAATCGCCTATCCTTTCAATAAGTTGTGTTACGCTATCGGTGACGGAACTACTCCAGCTGGTAATACACATTTGGTCTGTTTCGGTAATAGCGCCAATCATATCCAACCCGATGAGGACGTTAGAGAAACCCTGAAAGCTGTTGGTCAACTGGCTCCTGGTACCTTTGGTGTTAAAAGATTGGTGTTCCACAATTGGGTGAAAGATGAGTTTGCTAAAGGAGCATGGTTCTTTTCAAGACCAGGTATGGTTTCTGAGTGCCTGCAAGGATTAAGAGAGAAGCACCGAGGAGTAGTGTTCGCAAATTCCGATTGGGCCCTTGGATGGAGGTCTTTTATCGACGGTGCAATTGAAGAGGGTACGAGAGCTGCGAGGGTCGTCTTGGAGGAGCTTGGCACTAAAAGGGAGGTAAAGGCTCGTTTGTAATACGTAGAATTCCCTAGGGCGGCCGCGAATTAATTCGCCTTAGACATGACTGTTCCTCAGTTCAAGTTGGGCACTTACGAGAAGACCGGTCTTGCTAGATTCTAATCAAGAGGATGTCAGAATGCCATTTGCCTGAGAGATGCAGGCTTCATTTTTGATACTTTTTTATTTGTAACCTATATAGTATAGGATTTTTTTTGTCATTTTGTTTCTTCTCGTACGAGCTTGCTCCTGATCAGCCTATCTCGCAGCTGATGAATATCTTGTGGTAGGGGTTTGGGAAAATCATTCGAGTTTGATGTTTTTCTTGGTATTTCCCACTCCTCTTCAGAGTACAGAAGATTAAGTGAGAAGTTCGTTTGTGCAAGCTTATCGATAAGCTTTAATGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGGCACCGTGTATGAAATCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGCATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGCGGGATATCGTCCATTCCGACAGCATCGCCAGTCACTATGGCGTGCTGCTAGCGCTATATGCGTTGATGCAATTTCTATGCGCACCCGTTCTCGGAGCACTGTCCGACCGCTTTGGCCGCCGCCCAGTCCTGCTCGCTTCGCTACTTGGAGCCACTATCGACTACGCGATCATGGCGACCACACCCGTCCTGTGGATCTATCGAATCTAAATGTAAGTTAAAATCTCTAAATAATTAAATAAGTCCCAGTTTCTCCATACGAACCTTAACAGCATTGCGGTGAGCATCTAGACCTTCAACAGCAGCCAGATCCATCACTGCTTGGCCAATATGTTTCAGTCCCTCAGGAGTTACGTCTTGTGAAGTGATGAACTTCTGGAAGGTTGCAGTGTTAACTCCGCTGTATTGACGGGCATATCCGTACGTTGGCAAAGTGTGGTTGGTACCGGAGGAGTAATCTCCACAACTCTCTGGAGAGTAGGCACCAACAAACACAGATCCAGCGTGTTGTACTTGATCAACATAAGAAGAAGCATTCTCGATTTGCAGGATCAAGTGTTCAGGAGCGTACTGATTGGACATTTCCAAAGCCTGCTCGTAGGTTGCAACCGATAGGGTTGTAGAGTGTGCAATACACTTGCGTACAATTTCAACCCTTGGCAACTGCACAGCTTGGTTGTGAACAGCATCTTCAATTCTGGCAAGCTCCTTGTCTGTCATATCGACAGCCAACAGAATCACCTGGGAATCAATACCATGTTCAGCTTGAGACAGAAGGTCTGAGGCAACGAAATCTGGATCAGCGTATTTATCAGCAATAACTAGAACTTCAGAAGGCCCAGCAGGCATGTCAATACTACACAGGGCTGATGTGTCATTTTGAACCATCATCTTGGCAGCAGTAACGAACTGGTTTCCTGGACCAAATATTTTGTCACACTTAGGAACAGTTTCTGTTCCGTAAGCCATAGCAGCTACTGCCTGGGCGCCTCCTGCTAGCACGATACACTTAGCACCAACCTTGTGGGCAACGTAGATGACTTCTGGGGTAAGGGTACCATCCTTCTTAGGTGGAGATGCAAAAACAATTTCTTTGCAACCAGCAACTTTGGCAGGAACACCCAGCATCAGGGAAGTGGAAGGCAGAATTGCGGTTCCACCAGGAATATAGAGGCCAACTTTCTCAATAGGTCTTGCAAAACGAGAGCAGACTACACCAGGGCAAGTCTCAACTTGCAACGTCTCCGTTAGTTGAGCTTCATGGAATTTCCTGACGTTATCTATAGAGAGATCAATGGCTCTCTTAACGTTATCTGGCAATTGCATAAGTTCCTCTGGGAAAGGAGCTTCTAACACAGGTGTCTTCAAAGCGACTCCATCAAACTTGGCAGTTAGTTCTAAAAGGGCTTTGTCACCATTTTGACGAACATTGTCGACAATTGGTTTGACTAATTCCATAATCTGTTCCGTTTTCTGGATAGGACGACGAAGGGCATCTTCAATTTCTTGTGAGGAGGCCTTAGAAACGTCAATTTTGCACAATTCAATACGACCTTCAGAAGGGACTTCTTTAGGTTTGGATTCTTCTTTAGGTTGTTCCTTGGTGTATCCTGGCTTGGCATCTCCTTTCCTTCTAGTGACCTTTAGGGACTTCATATCCAGGTTTCTCTCCACCTCGTCCAACGTCACACCGTACTTGGCACATCTAACTAATGCAAAATAAAATAAGTCAGCACATTCCCAGGCTATATCTTCCTTGGATTTAGCTTCTGCAAGTTCATCAGCTTCCTCCCTAATTTTAGCGTTCAACAAAACTTCGTCGTCAAATAACCGTTTGGTATAAGAACCTTCTGGAGCATTGCTCTTACGATCCCACAAGGTGGCTTCCATGGCTCTAAGACCCTTTGATTGGCCAAAACAGGAAGTGCGTTCCAAGTGACAGAAACCAACACCTGTTTGTTCAACCACAAATTTCAAGCAGTCTCCATCACAATCCAATTCGATACCCAGCAACTTTTGAGTTGCTCCAGATGTAGCACCTTTATACCACAAACCGTGACGACGAGATTGGTAGACTCCAGTTTGTGTCCTTATAGCCTCCGGAATAGACTTTTTGGACGAGTACACCAGGCCCAACGAGTAATTAGAAGAGTCAGCCACCAAAGTAGTGAATAGACCATCGGGGCGGTCAGTAGTCAAAGACGCCAACAAAATTTCACTGACAGGGAACTTTTTGACATCTTCAGAAAGTTCGTATTCAGTAGTCAATTGCCGAGCATCAATAATGGGGATTATACCAGAAGCAACAGTGGAAGTCACATCTACCAACTTTGCGGTCTCAGAAAAAGCATAAACAGTTCTACTACCGCCATTAGTGAAACTTTTCAAATCGCCCAGTGGAGAAGAAAAAGGCACAGCGATACTAGCATTAGCGGGCAAGGATGCAACTTTATCAACCAGGGTCCTATAGATAACCCTAGCGCCTGGGATCATCCTTTGGACAACTCTTTCTGCCAAATCTAGGTCCAAAATCACTTCATTGATACCATTATTGTACAACTTGAGCAAGTTGTCGATCAGCTCCTCAAATTGGTCCTCTGTAACGGATGACTCAACTTGCACATTAACTTGAAGCTCAGTCGATTGAGTGAACTTGATCAGGTTGTGCAGCTGGTCAGCAGCATAGGGAAACACGGCTTTTCCTACCAAACTCAAGGAATTATCAAACTCTGCAACACTTGCGTATGCAGGTAGCAAGGGAAATGTCATACTTGAAGTCGGACAGTGAGTGTAGTCTTGAGAAATTCTGAAGCCGTATTTTTATTATCAGTGAGTCAGTCATCAGGAGATCCTCTACGCCGGACGCATCGTGGCCGACCTGCAGGGGGGGGGGGGGCGCTGAGGTCTGCCTCGTGAAGAAGGTGTTGCTGACTCATACCAGGCCTGAATCGCCCCATCATCCAGCCAGAAAGTGAGGGAGCCACGGTTGATGAGAGCTTTGTTGTAGGTGGACCAGTTGGTGATTTTGAACTTTTGCTTTGCCACGGAACGGTCTGCGTTGTCGGGAAGATGCGTGATCTGATCCTTCAACTCAGCAAAAGTTCGATTTATTCAACAAAGCCGCCGTCCCGTCAAGTCAGCGTAATGCTCTGCCAGTGTTACAACCAATTAACCAATTCTGATTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTCGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAGAGATTTTGAGACACAACGTGGCTTTCCCCCCCCCCCCTGCAGGTCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCGCATAAGGGAGAGCGTCGAGTATCTATGATTGGAAGTATGGGAATGGTGATACCCGCATTCTTCAGTGTCTTGAGGTCTCCTATCAGATTATGCCCAACTAAAGCAACCGGAGGAGGAGATTTCATGGTAAATTTCTCTGACTTTTGGTCATCAGTAGACTCGAACTGTGAGACTATCTCGGTTATGACAGCAGAAATGTCCTTCTTGGAGACAGTAAATGAAGTCCCACCAATAAAGAAATCCTTGTTATCAGGAACAAACTTCTTGTTTCGAACTTTTTCGGTGCCTTGAACTATAAAATGTAGAGTGGATATGTCGGGTAGGAATGGAGCGGGCAAATGCTTACCTTCTGGACCTTCAAGAGGTATGTAGGGTTTGTAGATACTGATGCCAACTTCAGTGACAACGTTGCTATTTCGTTCAAACCATTCCGAATCCAGAGAAATCAAAGTTGTTTGTCTACTATTGATCCAAGCCAGTGCGGTCTTGAAACTGACAATAGTGTGCTCGTGTTTTGAGGTCATCTTTGTATGAATAAATCTAGTCTTTGATCTAAATAATCTTGACGAGCCAAGGCGATAAATACCCAAATCTAAAACTCTTTTAAAACGTTAAAAGGACAAGTATGTCTGCCTGTATTAAACCCCAAATCAGCTCGTAGTCTGATCCTCATCAACTTGAGGGGCACTATCTTGTTTTAGAGAAATTTGCGGAGATGCGATATCGAGAAAAAGGTACGCTGATTTTAAACGTGAAATTTATCTCAAGATCTCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAATGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAACACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAATTAATTCTCATGTTTGACAGCTTATCATCGATAAGCTGACTCATGTTGGTATTGTGAAATAGACGCAGATCGGGAACACTGAAAAATAACAGTTATTATTCG( As shown in SEQ ID NO. 2
Wherein the underline is CT05 gene, the bold part is PAM site, the italic part is specific recognition sequence (20 bp)
Thus crRNA sequence is:
5 'UAAUUUCUACUAAGUGUUAGAUAUAUGCAUCUUAAGGGAUC 3' (shown in SEQ ID NO: 3)
Wherein: the non-underlined part is the structural sequence and the underlined part is the recognition sequence.
Experimental operation:
From the solid medium incubated overnight at 37℃the monoclonal colonies were picked up, and in 10. Mu.L of the medium, 1. Mu.L of the bacterial liquid was added to 30. Mu.L of bufferI prepared in example 1, followed by 5. Mu.L of the snail protease solution prepared in example 1. The reaction was carried out at 37℃and 600rpm for 30min. 2 mu L of the reaction solution is added into the pre-prepared detection system of the example 2 (see table 10), and the reaction is carried out for 15min at 37 ℃, so that the experimental result can be observed under ultraviolet light (figure 4), and meanwhile, colony PCR is used for screening, and the result is shown in figure 5.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Sequence listing
<110> Shenzhen Ruidelin Biotechnology Co., ltd
<120> Fungus screening reagent, screening method, kit and application
<130> S21P003752
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 41
<212> RNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 1
uaauuucuac uaaguguaga ugauugccgg acccggaccg c 41
<210> 2
<211> 10782
<212> DNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 2
agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60
gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120
tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180
agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240
acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300
tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360
agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420
gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480
ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcgcca taccgtttgt 540
cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600
ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660
ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720
gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780
atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840
actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900
caacttgaga agatcaaaaa acaactaatt attcgaagga tccaaacgat gagatttcct 960
tcaattttta ctgcagtttt attcgcagca tcctccgcat tagctgctcc agtcaacact 1020
acaacagaag atgaaacggc acaaattccg gctgaagctg tcatcggtta ctcagattta 1080
gaaggggatt tcgatgttgc tgttttgcca ttttccaaca gcacaaataa cgggttattg 1140
tttataaata ctactattgc cagcattgct gctaaagaag aaggggtatc tctcgagaaa 1200
agagaggctg aagctatgca ccaccatcat caccatactt ctcgtgacgg ctaccaatgg 1260
acacctgaaa ctggtttgac tcagggtgtg ccatccctag gagttatctc tccaccaacg 1320
aacatagagg acacggataa ggacggccct tgggacgtga tcgtaattgg aggaggatat 1380
tgcggtttaa ctgcaacacg tgatctcact gtagccggtt ttaagacttt attgttagag 1440
gcaagagatc gtattggagg tagatcgtgg tcctccaata ttgacggtta tccttacgaa 1500
atgggtggga cctgggttca ttggcaccaa tctcatgtgt ggagagagat cacacgttac 1560
aaaatgcata atgctttgtc cccctccttc aacttttcaa gaggtgtcaa ccactttcaa 1620
ctgagaacaa atccaacaac ctcgacatat atgactcatg aagcagagga tgaattgctt 1680
agatcagctt tgcataagtt cacaaatgtt gacggtacga acggcagaac tgttttaccg 1740
ttccctcacg atatgttcta tgtccccgaa tttcgaaaat acgacgagat gagttactcc 1800
gaacgtattg atcaaatacg tgatgaattg agtctgaatg agagaagcag cctagaagca 1860
ttcatcctgt tgtgttcagg tggtacactt gaaaactctt cgttcggaga atttctccat 1920
tggtgggcta tgtctggtta cacatatcag ggttgtatgg attgtctaat gagctataag 1980
tttaaggatg gtcagagtgc ttttgctaga agattctggg aagaggctgc tggaactggt 2040
agattgggat acgttttcgg ttgtcctgtc aggtccgtgg ttaacgaaag ggatgctgca 2100
agagtaacag caagagatgg tcgtgaattt gccgctaaaa ggctggtttg tactattcca 2160
ttgaatgtct tgtccaccat tcaatttagt ccagcacttt caacagaacg tattagcgcc 2220
atgcaggctg gtcatgtgag catgtgcacc aaagttcacg cagaagttga caacaaggac 2280
atgagatcat ggactggaat cgcctatcct ttcaataagt tgtgttacgc tatcggtgac 2340
ggaactactc cagctggtaa tacacatttg gtctgtttcg gtaatagcgc caatcatatc 2400
caacccgatg aggacgttag agaaaccctg aaagctgttg gtcaactggc tcctggtacc 2460
tttggtgtta aaagattggt gttccacaat tgggtgaaag atgagtttgc taaaggagca 2520
tggttctttt caagaccagg tatggtttct gagtgcctgc aaggattaag agagaagcac 2580
cgaggagtag tgttcgcaaa ttccgattgg gcccttggat ggaggtcttt tatcgacggt 2640
gcaattgaag agggtacgag agctgcgagg gtcgtcttgg aggagcttgg cactaaaagg 2700
gaggtaaagg ctcgtttgta atacgtagaa ttccctaggg cggccgcgaa ttaattcgcc 2760
ttagacatga ctgttcctca gttcaagttg ggcacttacg agaagaccgg tcttgctaga 2820
ttctaatcaa gaggatgtca gaatgccatt tgcctgagag atgcaggctt catttttgat 2880
acttttttat ttgtaaccta tatagtatag gatttttttt gtcattttgt ttcttctcgt 2940
acgagcttgc tcctgatcag cctatctcgc agctgatgaa tatcttgtgg taggggtttg 3000
ggaaaatcat tcgagtttga tgtttttctt ggtatttccc actcctcttc agagtacaga 3060
agattaagtg agaagttcgt ttgtgcaagc ttatcgataa gctttaatgc ggtagtttat 3120
cacagttaaa ttgctaacgc agtcaggcac cgtgtatgaa atctaacaat gcgctcatcg 3180
tcatcctcgg caccgtcacc ctggatgctg taggcatagg cttggttatg ccggtactgc 3240
cgggcctctt gcgggatatc gtccattccg acagcatcgc cagtcactat ggcgtgctgc 3300
tagcgctata tgcgttgatg caatttctat gcgcacccgt tctcggagca ctgtccgacc 3360
gctttggccg ccgcccagtc ctgctcgctt cgctacttgg agccactatc gactacgcga 3420
tcatggcgac cacacccgtc ctgtggatct atcgaatcta aatgtaagtt aaaatctcta 3480
aataattaaa taagtcccag tttctccata cgaaccttaa cagcattgcg gtgagcatct 3540
agaccttcaa cagcagccag atccatcact gcttggccaa tatgtttcag tccctcagga 3600
gttacgtctt gtgaagtgat gaacttctgg aaggttgcag tgttaactcc gctgtattga 3660
cgggcatatc cgtacgttgg caaagtgtgg ttggtaccgg aggagtaatc tccacaactc 3720
tctggagagt aggcaccaac aaacacagat ccagcgtgtt gtacttgatc aacataagaa 3780
gaagcattct cgatttgcag gatcaagtgt tcaggagcgt actgattgga catttccaaa 3840
gcctgctcgt aggttgcaac cgatagggtt gtagagtgtg caatacactt gcgtacaatt 3900
tcaacccttg gcaactgcac agcttggttg tgaacagcat cttcaattct ggcaagctcc 3960
ttgtctgtca tatcgacagc caacagaatc acctgggaat caataccatg ttcagcttga 4020
gacagaaggt ctgaggcaac gaaatctgga tcagcgtatt tatcagcaat aactagaact 4080
tcagaaggcc cagcaggcat gtcaatacta cacagggctg atgtgtcatt ttgaaccatc 4140
atcttggcag cagtaacgaa ctggtttcct ggaccaaata ttttgtcaca cttaggaaca 4200
gtttctgttc cgtaagccat agcagctact gcctgggcgc ctcctgctag cacgatacac 4260
ttagcaccaa ccttgtgggc aacgtagatg acttctgggg taagggtacc atccttctta 4320
ggtggagatg caaaaacaat ttctttgcaa ccagcaactt tggcaggaac acccagcatc 4380
agggaagtgg aaggcagaat tgcggttcca ccaggaatat agaggccaac tttctcaata 4440
ggtcttgcaa aacgagagca gactacacca gggcaagtct caacttgcaa cgtctccgtt 4500
agttgagctt catggaattt cctgacgtta tctatagaga gatcaatggc tctcttaacg 4560
ttatctggca attgcataag ttcctctggg aaaggagctt ctaacacagg tgtcttcaaa 4620
gcgactccat caaacttggc agttagttct aaaagggctt tgtcaccatt ttgacgaaca 4680
ttgtcgacaa ttggtttgac taattccata atctgttccg ttttctggat aggacgacga 4740
agggcatctt caatttcttg tgaggaggcc ttagaaacgt caattttgca caattcaata 4800
cgaccttcag aagggacttc tttaggtttg gattcttctt taggttgttc cttggtgtat 4860
cctggcttgg catctccttt ccttctagtg acctttaggg acttcatatc caggtttctc 4920
tccacctcgt ccaacgtcac accgtacttg gcacatctaa ctaatgcaaa ataaaataag 4980
tcagcacatt cccaggctat atcttccttg gatttagctt ctgcaagttc atcagcttcc 5040
tccctaattt tagcgttcaa caaaacttcg tcgtcaaata accgtttggt ataagaacct 5100
tctggagcat tgctcttacg atcccacaag gtggcttcca tggctctaag accctttgat 5160
tggccaaaac aggaagtgcg ttccaagtga cagaaaccaa cacctgtttg ttcaaccaca 5220
aatttcaagc agtctccatc acaatccaat tcgataccca gcaacttttg agttgctcca 5280
gatgtagcac ctttatacca caaaccgtga cgacgagatt ggtagactcc agtttgtgtc 5340
cttatagcct ccggaataga ctttttggac gagtacacca ggcccaacga gtaattagaa 5400
gagtcagcca ccaaagtagt gaatagacca tcggggcggt cagtagtcaa agacgccaac 5460
aaaatttcac tgacagggaa ctttttgaca tcttcagaaa gttcgtattc agtagtcaat 5520
tgccgagcat caataatggg gattatacca gaagcaacag tggaagtcac atctaccaac 5580
tttgcggtct cagaaaaagc ataaacagtt ctactaccgc cattagtgaa acttttcaaa 5640
tcgcccagtg gagaagaaaa aggcacagcg atactagcat tagcgggcaa ggatgcaact 5700
ttatcaacca gggtcctata gataacccta gcgcctggga tcatcctttg gacaactctt 5760
tctgccaaat ctaggtccaa aatcacttca ttgataccat tattgtacaa cttgagcaag 5820
ttgtcgatca gctcctcaaa ttggtcctct gtaacggatg actcaacttg cacattaact 5880
tgaagctcag tcgattgagt gaacttgatc aggttgtgca gctggtcagc agcataggga 5940
aacacggctt ttcctaccaa actcaaggaa ttatcaaact ctgcaacact tgcgtatgca 6000
ggtagcaagg gaaatgtcat acttgaagtc ggacagtgag tgtagtcttg agaaattctg 6060
aagccgtatt tttattatca gtgagtcagt catcaggaga tcctctacgc cggacgcatc 6120
gtggccgacc tgcagggggg gggggggcgc tgaggtctgc ctcgtgaaga aggtgttgct 6180
gactcatacc aggcctgaat cgccccatca tccagccaga aagtgaggga gccacggttg 6240
atgagagctt tgttgtaggt ggaccagttg gtgattttga acttttgctt tgccacggaa 6300
cggtctgcgt tgtcgggaag atgcgtgatc tgatccttca actcagcaaa agttcgattt 6360
attcaacaaa gccgccgtcc cgtcaagtca gcgtaatgct ctgccagtgt tacaaccaat 6420
taaccaattc tgattagaaa aactcatcga gcatcaaatg aaactgcaat ttattcatat 6480
caggattatc aataccatat ttttgaaaaa gccgtttctg taatgaagga gaaaactcac 6540
cgaggcagtt ccataggatg gcaagatcct ggtatcggtc tgcgattccg actcgtccaa 6600
catcaataca acctattaat ttcccctcgt caaaaataag gttatcaagt gagaaatcac 6660
catgagtgac gactgaatcc ggtgagaatg gcaaaagctt atgcatttct ttccagactt 6720
gttcaacagg ccagccatta cgctcgtcat caaaatcact cgcatcaacc aaaccgttat 6780
tcattcgtga ttgcgcctga gcgagacgaa atacgcgatc gctgttaaaa ggacaattac 6840
aaacaggaat cgaatgcaac cggcgcagga acactgccag cgcatcaaca atattttcac 6900
ctgaatcagg atattcttct aatacctgga atgctgtttt cccggggatc gcagtggtga 6960
gtaaccatgc atcatcagga gtacggataa aatgcttgat ggtcggaaga ggcataaatt 7020
ccgtcagcca gtttagtctg accatctcat ctgtaacatc attggcaacg ctacctttgc 7080
catgtttcag aaacaactct ggcgcatcgg gcttcccata caatcgatag attgtcgcac 7140
ctgattgccc gacattatcg cgagcccatt tatacccata taaatcagca tccatgttgg 7200
aatttaatcg cggcctcgag caagacgttt cccgttgaat atggctcata acaccccttg 7260
tattactgtt tatgtaagca gacagtttta ttgttcatga tgatatattt ttatcttgtg 7320
caatgtaaca tcagagattt tgagacacaa cgtggctttc cccccccccc ctgcaggtcg 7380
gcatcaccgg cgccacaggt gcggttgctg gcgcctatat cgccgacatc accgatgggg 7440
aagatcgggc tcgccacttc gggctcatga gcgcttgttt cggcgtgggt atggtggcag 7500
gccccgtggc cgggggactg ttgggcgcca tctccttgca tgcaccattc cttgcggcgg 7560
cggtgctcaa cggcctcaac ctactactgg gctgcttcct aatgcaggag tcgcataagg 7620
gagagcgtcg agtatctatg attggaagta tgggaatggt gatacccgca ttcttcagtg 7680
tcttgaggtc tcctatcaga ttatgcccaa ctaaagcaac cggaggagga gatttcatgg 7740
taaatttctc tgacttttgg tcatcagtag actcgaactg tgagactatc tcggttatga 7800
cagcagaaat gtccttcttg gagacagtaa atgaagtccc accaataaag aaatccttgt 7860
tatcaggaac aaacttcttg tttcgaactt tttcggtgcc ttgaactata aaatgtagag 7920
tggatatgtc gggtaggaat ggagcgggca aatgcttacc ttctggacct tcaagaggta 7980
tgtagggttt gtagatactg atgccaactt cagtgacaac gttgctattt cgttcaaacc 8040
attccgaatc cagagaaatc aaagttgttt gtctactatt gatccaagcc agtgcggtct 8100
tgaaactgac aatagtgtgc tcgtgttttg aggtcatctt tgtatgaata aatctagtct 8160
ttgatctaaa taatcttgac gagccaaggc gataaatacc caaatctaaa actcttttaa 8220
aacgttaaaa ggacaagtat gtctgcctgt attaaacccc aaatcagctc gtagtctgat 8280
cctcatcaac ttgaggggca ctatcttgtt ttagagaaat ttgcggagat gcgatatcga 8340
gaaaaaggta cgctgatttt aaacgtgaaa tttatctcaa gatctctgcc tcgcgcgttt 8400
cggtgatgac ggtgaaaacc tctgacacat gcagctcccg gagacggtca cagcttgtct 8460
gtaagcggat gccgggagca gacaagcccg tcagggcgcg tcagcgggtg ttggcgggtg 8520
tcggggcgca gccatgaccc agtcacgtag cgatagcgga gtgtatactg gcttaactat 8580
gcggcatcag agcagattgt actgagagtg caccatatgc ggtgtgaaat accgcacaga 8640
tgcgtaagga gaaaataccg catcaggcgc tcttccgctt cctcgctcac tgactcgctg 8700
cgctcggtcg ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta 8760
tccacagaat caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc 8820
aggaaccgta aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag 8880
catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac 8940
caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc 9000
ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcaatg ctcacgctgt 9060
aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc 9120
gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga 9180
cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta 9240
ggcggtgcta cagagttctt gaagtggtgg cctaactacg gctacactag aaggacagta 9300
tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga 9360
tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca gcagattacg 9420
cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc tgacgctcag 9480
tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc 9540
tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact 9600
tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt 9660
cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta 9720
ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta 9780
tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc 9840
gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat 9900
agtttgcgca acgttgttgc cattgctgca ggcatcgtgg tgtcacgctc gtcgtttggt 9960
atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg 10020
tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca 10080
gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta 10140
agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg 10200
cgaccgagtt gctcttgccc ggcgtcaaca cgggataata ccgcgccaca tagcagaact 10260
ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg 10320
ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt 10380
actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga 10440
ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc 10500
atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa 10560
caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtcta agaaaccatt 10620
attatcatga cattaaccta taaaaatagg cgtatcacga ggccctttcg tcttcaagaa 10680
ttaattctca tgtttgacag cttatcatcg ataagctgac tcatgttggt attgtgaaat 10740
agacgcagat cgggaacact gaaaaataac agttattatt cg 10782
<210> 3
<211> 41
<212> RNA
<213> Artificial sequence (ARTIFICIAL SEQUENCE)
<400> 3
uaauuucuac uaaguguaga uauuaugcau cuuaagggau c 41
Claims (4)
1. A method for screening a fungal colony comprising the steps of:
S1: mixing a lysozyme reagent with a sample to obtain a mixed bacterial solution;
s2: mixing the mixed bacterial liquid with a detection reagent, and detecting;
The mixing time in the step S1 is 25-50 min, and the temperature is 35-38 ℃;
The lysozyme comprises the following components:
Sorbitol 0.9 mol/L
EDTA 0.1 mol/L
Snail protease 30 mg/mL;
The detection reagent comprises the following components:
1µM crRNA 100 nM
10nM Cas12a protein 0.5 nM
1NM fluorescent reporter 0.1 nM
The volume ratio of 10 XBuffer to ddH 2 O is 1:6;
The crRNA design method comprises the step of selecting a base sequence of 20 bp base sequences after a PAM locus TTTN on a target gene as a recognition sequence.
2. The screening method of claim 1, wherein the volume ratio of said lysozyme to said sample in S1 is 35:1.
3. The method of claim 1, wherein the mixing in S2 is performed for a period of 15 min and at a temperature of 35 to 38 ℃.
4. The application of the lysozyme and the detection reagent in detecting and/or screening fungus colonies;
The lysozyme comprises the following components:
Sorbitol 0.9 mol/L
EDTA 0.1 mol/L
Snail protease 30 mg/mL;
The detection reagent comprises the following components:
1µM crRNA 100 nM
10nM Cas12a protein 0.5 nM
1NM fluorescent reporter 0.1 nM
The volume ratio of 10 XBuffer to ddH 2 O is 1:6;
The crRNA design method comprises the step of selecting a base sequence of 20 bp base sequences after a PAM locus TTTN on a target gene as a recognition sequence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210103372.1A CN114438163B (en) | 2022-01-27 | 2022-01-27 | Fungus screening reagent, screening method, kit and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210103372.1A CN114438163B (en) | 2022-01-27 | 2022-01-27 | Fungus screening reagent, screening method, kit and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114438163A CN114438163A (en) | 2022-05-06 |
CN114438163B true CN114438163B (en) | 2024-05-14 |
Family
ID=81370621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210103372.1A Active CN114438163B (en) | 2022-01-27 | 2022-01-27 | Fungus screening reagent, screening method, kit and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114438163B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1641025A (en) * | 2004-11-29 | 2005-07-20 | 中国水产科学研究院黄海水产研究所 | Pagrosomus major antibacterial peptide gene, and recombinant yeast expression vector and its preparing method |
CN102230010A (en) * | 2011-06-14 | 2011-11-02 | 北京大北农科技集团股份有限公司 | Bacterial colony polymerase chain reaction (PCR) method and kit |
CN111394347A (en) * | 2020-03-26 | 2020-07-10 | 中国人民解放军联勤保障部队第九八〇医院 | Preparation method of candida-free nucleic acid sample suitable for PCR (polymerase chain reaction) experiment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190153475A1 (en) * | 2015-12-17 | 2019-05-23 | Evonik Degussa (China) Co., Ltd. | Gene cassette for homologous recombination knock-out in yeast cells |
-
2022
- 2022-01-27 CN CN202210103372.1A patent/CN114438163B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1641025A (en) * | 2004-11-29 | 2005-07-20 | 中国水产科学研究院黄海水产研究所 | Pagrosomus major antibacterial peptide gene, and recombinant yeast expression vector and its preparing method |
CN102230010A (en) * | 2011-06-14 | 2011-11-02 | 北京大北农科技集团股份有限公司 | Bacterial colony polymerase chain reaction (PCR) method and kit |
CN111394347A (en) * | 2020-03-26 | 2020-07-10 | 中国人民解放军联勤保障部队第九八〇医院 | Preparation method of candida-free nucleic acid sample suitable for PCR (polymerase chain reaction) experiment |
Non-Patent Citations (5)
Title |
---|
Cell permeability and nuclear DNA staining by propidium iodide in basidiomycetous yeasts;Ning Zhang等;Appl Microbiol Biotechnol;第102卷(第9期);4183-4191 * |
Juhong Chen等.Rapid genotypic antibiotic susceptibility test using CRISPR-Cas12a for urinary tract infection.Analyst.2020,第145卷(第15期),第5227页左栏第1段,右栏第4段. * |
Powerful tools for productivity improvements in microalgal production;Han Sun等;Renewable and Sustainable Energy Reviews;第152卷;111609 * |
Rapid genotypic antibiotic susceptibility test using CRISPR-Cas12a for urinary tract infection;Juhong Chen等;Analyst;第145卷(第15期);第5227页左栏第1段,右栏第4段 * |
利用CRISPR-Cas9技术失活黑曲霉中果胶酶基因及突变株性能评价;王艳梅等;中国生物工程杂志;第41卷(第5期);35-44 * |
Also Published As
Publication number | Publication date |
---|---|
CN114438163A (en) | 2022-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20080113199A (en) | Methods and compositions for ethanol producing cyanobacteria | |
CN114736893B (en) | Method for realizing A/T to G/C editing on mitochondrial DNA | |
CN108676848B (en) | Mixed gene, standard plasmid and kit for detecting fusion gene and preparation method thereof | |
CN103224955A (en) | Vector for efficiently labeling zebra fish PGC, and preparation method and use of transgenic fish | |
CN114957448B (en) | Yeast strain for efficiently expressing alpha-lactalbumin, alpha-lactalbumin and application thereof | |
CN114438163B (en) | Fungus screening reagent, screening method, kit and application | |
CN110093277A (en) | Toxoplasma Gallus gallusShouguang strain knocks out the construction method and purposes of worm strain | |
CN109468338A (en) | A kind of method of purpose pU6-sgRNA plasmid needed for rapid build caenorhabditis elegan gene editing | |
CN108085371B (en) | Method for judging whether PCR result is false positive | |
CN114959110A (en) | Kit for detecting hepatitis B virus pregenomic RNA based on PCR-CRISPR-Cas13a | |
CN114874927B (en) | Yeast genetic engineering bacterium for high-yield recombinant protein, construction method and application thereof | |
CN112553098B (en) | Biological preparation method of caffeic acid | |
CN102703474A (en) | New bunyavirus NP protein coding sequence and application thereof | |
CN113493855B (en) | Kit for detecting HBV cccDNA based on RAA-CRISPR-cas13a | |
CN114959107A (en) | Kit for detecting hepatitis B virus DNA based on RAA-CRISPR-Cas13a technology | |
CN101597622A (en) | The series miRNA or the shRNA expression vector of tumor-specific promoters regulation and control | |
CN108949793B (en) | Recombinant bacterium for representing genetic toxicity and construction method and application thereof | |
CN101659967B (en) | PiggyBac transposon vector for producing transgenic pig and construction method thereof | |
Walter et al. | Method for multiplexed integration of synergistic alleles and metabolic pathways in yeasts via CRISPR-Cas9 | |
CN114149975B (en) | Cell model with specific HBV sequence inserted into specific gene region, construction method and application thereof | |
CN101481703A (en) | Avian origin promoter expression vector, construction method and use thereof | |
CN108715888A (en) | A kind of homogeneous detecting systems of PCR based on FRET and its application | |
CN106399223B (en) | A kind of separation of tripterygium wilfordii protoplast and transient transformation methods | |
CN113832091A (en) | Bacillus thuringiensis engineering bacterium for expressing bivalent insecticidal protein, and construction method and application thereof | |
JPH10248585A (en) | In vitro transcription for screening natural substance and other chemical substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 518000 floor 3, building 2, Shenzhen biological incubation base, No. 10, Gaoxin Zhongyi Road, Maling community, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant after: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. Address before: 518000 Room 101, 1st floor, building 2, Shenzhen biological incubation base, No.10, Gaoxin middle 1st Road, Maling community, Yuehai street, Nanshan District, Shenzhen City, Guangdong Province Applicant before: SHENZHEN READLINE BIOTECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |